Publications

A selection of leading publications and our contributions to advance the learning on CAR T-cell therapies.

Kyverna Publications

Anti-CD19 CAR T cells for refractory myasthenia gravis

Haghikia A, et al.

Lancet Neurology 2023;22:P1104-1105

Other Publications of Interest

CAR T-cell therapy in autoimmune diseases

Schett G, et al.

Lancet 2023;402:2034-2044

CD19-targeted CAR T cells in refractory antisynthetase syndrome

Müller F, et al.

Lancet 2023;401(10379):815-818

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Mackensen A, et al.

Nat Med 2022;28:2424-2132

CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

Mougiakakos D, et al.

N Engl J Med 2021;385:567-569

Stay up-to-date

Follow our journey to develop a paradigm shift in the treatment of autoimmune diseases.